SEARCH

SEARCH BY CITATION

References

  • Abbott, F. M. (2002a) ‘The TRIPS Agreement, Access to Medicines, and the WTO Doha Ministerial Conference’, The Journal of World Intellectual Property, 5(1), 1552.
  • Abbott, F. M. (2002b) TRIPS Agreement and its Implications for Access to Medicines in Developing Countries, Report Commissioned by the CIPR as a Background Paper. Studypaper 2a, Commission on Intellectual Property rights.
  • Acconci, P. (2006) ‘L'accesso ai farmaci essenziali. Una questione ancora in attesa di soluzione’, in E. Sciso (ed.), L'Organizzazione mondiale del commercio. Bilanci e prospettive. LUISS University Press, Rome, pp. 13556.
  • Alston, P., Goodman, R. and Steiner, H. J., International Human Rights in Context: Law, Politics, Morals, 3rd edition. Oxford University Press, Oxford.
  • Biagdleng, T. (2008) ‘The Development-Balance of the TRIPS Agreement and Enforcement of Intellectual Property Rights’, in J. Malbon and C. Lawson (eds), Interpreting and Implementing the TRIPS Agreement, It is Fair? Edward Elgar, Cheltenham, pp. 97130.
  • Blakeney, M. (2001) Border Control of Intellectual Property Rights. Sweet & Maxwell, London.
  • Blakeney, M. (2006) ‘The Phenomenon of Counterfeiting and Piracy in the European Union: Factual Overview and Legal and Institutional Framework’, in O. Vrins and M. Schneider (eds), Enforcement of Intellectual Property Rights Through Border Measures. Oxford University Press, Oxford, pp. 334.
  • Blanchard, A. M., Gill, K. and Steinberg, J. (2007) A Practical Guide to Intellectual Property Issues in the Pharmaceutical Industry. EIPR Practice Series, London.
  • Bodenhausen, G. (1968) Guide to the Application of the Paris Convention for the Protection of Industrial Property as Revised at Stockholm in 1967. BIRPI, Geneva.
  • Boschiero, N. (2009) La nuova disciplina comunitaria della legge applicabile ai contratti. Giappichelli, Turin.
  • Carvalho, N. (2005) The TRIPS Regime of Patents Rights, 2nd edition. Kluwer Law International, The Hague.
  • Correa, C. (2002) Implications of the Doha Declaration on the TRIPS Agreement and Public Health. WHO, Geneva.
  • Cottier, T. (2008) Concise International and European IP Law. Kluwer Law International, The Hague.
  • Cronin, D. (2010) New Parliament Group Monitors EU Trade Pacts’ Impact on Poor's Medicines Access. Available at <http://www.ip-watch.org> [accessed October 2011].
  • Davey, W. and Zdouc, W. (2003) ‘The Triangle of GATT, GATS and TRIPS’, in T. Cottier, P. Mavroidis and M. Panizzon (eds), Intellectual Property: Trade, Competition and Sustainable Development: The World Trade Forum. The University of Michigan Press, Ann Arbor, MI.
  • Dinwoodie, G. (2004) ‘Trademarks and Territory: Detaching Trademark Law from the Nation-State’, Houston Law Review, 41(3), 885973.
  • Dinwoodie, G. (2006) ‘The International Intellectual Property Law System: New Actors, New Institutions, New Sources’, Marquette Intellectual Property Law Review, 10(2), 20514.
  • Dordi, C. (2004) ‘Gli accordi sugli scambi di servizi’, in G. Venturini, L'Organizzazione Mondiale del Commercio. Giuffré, Milan, pp. 65130.
  • Drahos, P. (1996) A Philosophy of Intellectual Property. Aldershot, Dartmouth.
  • European Commission (2001) WTO Ministerial Declaration on the TRIPS Agreement and Public Health—The Issues at Stake. Explanatory Note, Brussels.
  • Fatiguso, R. (2007) Le navi delle false griffe. Il Sole 24 Ore, Milano.
  • Fentiman, R. (2005) ‘Choice of Law and Intellectual Property’, in J. Drexl and A. Kur (eds), Intellectual Property and Private International Law, Hart, Oxford, pp. 12937.
  • Frankel, S. (2005), ‘The WTO's Application of ‘the Customary Rules of Interpretation of Public International Law’ to Intellectual Property’, Virginia Journal of International Law, 46.
  • Frankel, S. (2010), ‘The Applicability of GATT Jurisprudence to the Interpretation of the TRIPS Agreement’, in C. Correa (ed.), Research Handbook on the Interpretation and Enforcement of Intellectual Property under WTO Rules. Edward Elgar, Cheltenham, pp. 323.
  • Gadbaw, M. (1989) ‘Intellectual Property and International Trade: Merger or Marriage of Convenience?’, Vanderbilt Journal of Transnational Law, 22(2), 22342.
  • Gardiner, R. (2008) Treaty Interpretation. Oxford University Press, Oxford.
  • Gathii, J. T. (2002) ‘The Doha Declaration on TRIPS and Public Health under the Vienna Convention on the Law of the Treaties’, Harvard Journal of Law and Technology, 15(2), 292317.
  • Gervais, D. (1998) The TRIPS Agreement, Drafting History and Analysis. Sweet & Maxwell, London.
  • Gervais, D. (2008) The TRIPS Agreement. Sweet & Maxwell, London.
  • Grosse Ruse-Khan, H. and Jaeger, T. (2009) ‘Policing Patents Worldwide? EC Border Measures Against Transiting Generic Drugs under EC and WTO Intellectual Property Regimes’, International Review of Intellectual Property and Competition Law, 40(5), 50237.
  • Haugen, H. (2007) ‘General Comment No. 17 on “Authors’ Rights”’, The Journal of World Intellectual Property, 10(1), 5369.
  • Helfer, L. (2004) ‘Regime Shifting: The TRIPS Agreement and New Dynamics of International Intellectual Property Lawmaking’, Yale Journal of International Law, 29(1), 184.
  • Hestermeyer, H. (2007), Human Rights and the WTO. Oxford University Press, Oxford.
  • Howse, R. (2000) ‘The Canadian Generic Medicines Panel, a Dangerous Precedent in Dangerous Times’, The Journal of World Intellectual Property, 3(4), 493507.
  • Karl, W. (1984) Conflicts Between Treaties, in R. Bernhardt (ed.), Encyclopaedia of Public International Law, North Holland, Amsterdam.
  • Kongolo, T. (2008) Unsettled International Intellectual Property Issues. Kluwer Law International, Alphen aan den Rijn.
  • Kumar, S. P. (2010) ‘International Trade, Public Health, and Intellectual Property Maximalism: The Case of European Border Enforcement and Trade in Generic Pharmaceuticals’, Global Trade and Customs Journal, 5(4), 15569.
  • Kur, A. (2005) ‘Applicable Law: An Alternative Proposal for International Regulation—The Max Planck Project on International Jurisdiction and Choice of Law’, Brooklyn Journal of International Law, 30(3), 95381.
  • Kur, A. and Grosse Ruse-Khan, H. (2008) Enough is Enough—The Notion of Binding Ceilings in International Intellectual Property Protection. Available at <http://ssrn.com> [accessed October 2011].
  • Law, A. (2009) Patents and Public Health. Baden-Baden, Nomos.
  • Lupone, A. (2004), ‘Aspetti della proprietà intellettuale attinenti al commercio’, in G. Venturini (ed.), L'Organizzazione Mondiale del Commercio. Giuffré, Milan.
  • Mara, K. (2010) Minister: India Anticipates European Fix To Law Delaying Generic Shipments. Available at <http://www.ip-watch.org> [accessed October 2011].
  • Mara, K. and New, W. (2009) ‘Drug Seizures in Frankfurt Spark Fears of EU-Wide Pattern’. Available at <http://www.ip-watch.org> [accessed October 2011].
  • Marceau, G. (2002) ‘WTO Dispute Settlement and Human Rights’, European Journal of International Law, 13(4), 753814.
  • McGrady, B. (2008) ‘Fragmentation of International Law or “Systemic Integration” of Treaty Regimes: EC-Biotech Products and the Proper Interpretation of Article 31(3)(c) of the Vienna Convention on the Law of the Treaties’, The Journal of World Trade, 42(4), 589618.
  • Micara, A. (2007) ‘Contraffazione, pirateria e misure internazionali per il rispetto dei diritti di proprietà intellettuale’, Diritto del Commercio Internazionale, 21(3), 66580.
  • Musungu, S. (2008) ‘The TRIPS Agreement and Public Health’, in C. Correa and A. Yusuf (eds), Intellectual Property and International Trade: The TRIPS Agreement, 2nd edition. Kluwer Law International, Alphen aan den Rijn, pp. 42170.
  • OECD (2007) The Economic Impact of Counterfeiting and Piracy, Executive Summary. Available at <http://www.oecd.org/dataoecd/13/12/38707619.pdf> [accessed October 2011].
  • Otten, A. and Wager, H. (1996) ‘Compliance with TRIPS: The Emerging World View’, Vanderbilt Journal of Transnational Law, 29(3), 391413.
  • Outterson, K. (2009) Import Safety Rules Should Not Hinder Legitimate Generic Drug Markets, Working Paper No. 925, Boston University School of Law.
  • Pauwelyn, J. (2003) Conflict of Norms in Public International Law. Cambridge University Press, Cambridge.
  • Picone, P. and Ligustro, A. (2002) Diritto dell'Organizzazione Mondiale del Commercio. Cedam, Padova.
  • Puissochet, J. (2005) ‘L'Organizzazione Mondiale del Commercio e il diritto comunitario nella giurisprudenza della Corte di giustizia delle Comunità europee’, in F. Francioni, F. Lenzerini and M. Montini (eds), Organizzazione mondiale del commercio e diritto della Comunità europea nella prospettiva della risoluzione delle controversie. Giuffré, Milan, pp. 11731.
  • Reboul, Y., Py, E. and Thomas, S. (2004) Impacts de la contrefaçon et de la piraterie en Europe. Available at <http://www.ceipi.edu/index.php?id=5530#c35661> [accessed October 2011].
  • Reichmann, J. (1989) ‘Intellectual Property in International Trade: Opportunities and Risks of a GATT Connection’, Vanderbilt Journal of Transnational Law, 22, 747892.
  • Reichmann, J. (2008) ‘Universal Minimum Standards of Intellectual Property Protection under the TRIPS Component of the WTO Agreement’, in C. Correa and A. Yusuf (eds), Intellectual Property and International Trade: The TRIPS Agreement, 2nd edition. Kluwer Law International, Alphen aan den Rijn, pp. 2382.
  • Roffe, P., Spennemann, C. and Von Braun, J. (2006) ‘From Paris to Doha: The WTO Doha Declaration on the TRIPS Agreement and Public Health’, in P. Roffe, G. Tansey and D. Vivas-Egui (eds), Negotiating Health, Intellectual Property and Access to medicines. Earthscan, London.
  • Seuba, X. (2009) Border Measures Concerning Goods Allegedly Infringing Intellectual Property Rights: The Seizures of Generic Medicines in Transit, ICTSD Working Paper, Geneva.
  • Shanker, D. (2002) ‘The Vienna Convention on the Law of the Treaties, the Dispute Settlement System of the WTO and the Doha Declaration on the TRIPS Agreement’, Journal of World Trade, 36(4), 72172.
  • Sykes, A. O. (2002) TRIPS, Pharmaceuticals, Developing Countries, and the Doha ‘Solution’, J. M. Olin Working Law and Economics Working Paper No. 140, The Law School, The University of Chicago.
  • Third World Network (2009) WHO: Approach to “Counterfeit” Drugs may Affect Access to Medicines. Available at <http://www.twnside.org.sg/title2/wto.info/2009/twninfo20090101.htm> [accessed October 2011].
  • Tritton, G. (2002) Intellectual Property in Europe. Sweet & Maxwell, London.
  • UNCTAD, ICTSD (2005) Resource Book on TRIPS and Development. Cambridge University Press, Cambridge.
  • Van Damme, I. (2009) Treaty Interpretation by the WTO Appellate Body. Oxford University Press, Oxford.
  • Van Hezewijk, J. (2008) ‘Montex and Rolex: Irreconcilable Differences? A Call for a Better Definition of Counterfeit Goods’, International Review of Intellectual Property and Competition Law, 39(7), 77594.
  • Vrins, O. (2010) ‘The Real Story of a Fiction: Transit after Montex under Regulation EC 1383/2003’, Journal of Intellectual Property Law & Practice, 5(5), 35871.
  • Vrins, O. and Schneider, M. (2006) ‘Regulation (EC) 1383/2003’, in O. Vrins and M. Schneider (eds), Enforcement of Intellectual Property Rights Through Border Measures. Oxford University Press, Oxford, pp. 65174.
  • Vrins, O. and Schneider, M. (2008) Class Actions’ from Jacobs to Jacob. Available at <http://www.worldipreview.com/08/article5.html> [accessed May 2011].
  • WCO (2007) SECURE, Provisional Standards Employed by Customs for Uniform Rights Enforcement.
  • WHO (1999) Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs, WHO/EDM/QSM/99.1 <http://apps.who.int/medicinedocs/en/d/Jh1456e/> [accessed November 2011].
  • WHO (2008) Counterfeit Medical Products, Report by the Secretariat, 18, EB124/14.
  • WIPO, OHCHR (1998) Intellectual Property and Human Rights, Geneva.
  • Yamin, A. (2003) ‘Not Just a Tragedy: Access to Medications as a Right under International Law’, Boston University International Law Journal, 21(3), 32571.
  • Yu, P. (2007) ‘Reconceptualizing Intellectual Property Interests in a Human Rights Framework’, U.C. Davis Law Review, 40(3), 1039149.